Loading...
Loading...
Browse all stories on DeepNewz
VisitWill Moderna complete Phase 1 clinical trials for its mRNA bird flu vaccine by January 31, 2025?
Yes • 50%
No • 50%
Clinical trial registry and Moderna press releases
HHS Secretary Grants EUA for Moderna's $176M mRNA Bird Flu Vaccine
Jul 29, 2024, 09:35 PM
The U.S. Department of Health and Human Services (HHS) has awarded Moderna a $176 million contract to develop an mRNA vaccine for bird flu. This initiative is part of a broader plan to address potential bird flu outbreaks. The HHS Secretary has expanded emergencies to include bird flu, giving the FDA authority to issue Emergency Use Authorization (EUA) for these mRNA bird flu vaccines, similar to the process used during the COVID-19 pandemic. The University of Pennsylvania is also involved in the development of these vaccines.
View original story
Yes • 50%
No • 50%
Successful with no major side effects • 25%
Successful with some side effects • 25%
Unsuccessful • 25%
Inconclusive • 25%
Effective • 25%
Moderately Effective • 25%
Ineffective • 25%
Halted • 25%
No • 50%
Yes • 50%
5-10 million • 25%
More than 10 million • 25%
Less than 1 million • 25%
1-5 million • 25%
Evenly split • 25%
Majority positive • 25%
Insufficient data • 25%
Majority negative • 25%